Teladoc Health has been on the up-and-up throughout the course of the COVID-19 pandemic, and yesterday's earnings report suggests that the company is having little trouble booking new business.
In Q3 2020, the virtual care company outperformed its revenue and total visit projections, and fell about in line with its prediction of total U.S. paid membership and visit-fee-only access. However, the...
With Livongo and Teladoc’s merger expected to close in the fourth quarter of this year, the two companies recently announced the combined company leadership team, which won’t include Livongo’s CEO, CFO, president or SVP of business development.
Once the merger closes, Zane Burke, the CEO of Livongo, Lee Shapiro, the CFO of Livongo, Jennifer Schneider, the president of Livongo, and Steve Schwartz...
Digital check-in, insurance eligibility and automated patient collections technology company Clearwave today announced that it has purchased Odoro, the maker of a patient-scheduling and check-in tool. The companies did not disclose the terms of the deal, but said that they plan to integrate Odoro's scheduling technology into Clearwave's platform so that both the patient and practice can...
When it comes to taking bets on what’s next in healthcare, investors are often the ones calling the shots. Hemant Taneja, managing director of General Catalyst, has sat in the driver’s seat on some of the biggest digital health deals. His firm has invested in a number of digital health companies, from behavioral health company Mindstrong to fitness startup Tempo. But perhaps Taneja’s is best...
While the economy has been volatile during the pandemic, digital health companies to strike deals with investors raking in more money than ever before.
"We’ve already surpassed $7.5 billion in funding and are on track for this year to be the biggest funding year yet in terms of US-based digital health companies," Megan Zweig, chief operating officer at Rock Health, said during a fireside chat at...
More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.
The study looked at the proportion of Livongo members who had high blood pressure before and during the pandemic, specifically covering the time between mid-September of 2019 and mid-August of 2020.
The data does not support a...
(Photo by Kimberly White/Getty Images for TechCrunch)
Last week the digital health world was taken by storm when news broke that virtual health giant Teladoc was set to acquire chronic care management platform Livongo in a whopping $18.5 billion deal.
Livongo has had quite a year in a half. Last July, it went public with a listing price of $28 a share. At the time of the acquisition, each share was valued at roughly $159. Its news has also included...
The MobiHealthNews team members — host Jonah Comstock, Managing Editor Laura Lovett and Associate Editor Dave Muoio — sit down to unpack the major shakeup that hit the digital health markets this week when telemedicine giant Teladoc announced its plan to merge with chronic condition management success story Livongo. We talk details, motivations and implications of this digital health mega-company...
Shortly before news broke that Teladoc was set to acquire Livongo, the chronic disease management company announced its quarterly earnings results. On Aug. 5 it announced that its second quarter total revenue came in at $91.9 million, which was up 125% YoY. The company reported a GAAP gross margin of 76.6% and non-GAAP gross margin of 77.3%.
The company attributed the gains to its growing...
Digital health titans Teladoc Health and Livongo are merging under the Teladoc name. The deal values the 12-year-old digital chronic care-management company Livongo at $18.5 billion.
Teladoc CEO Jason Gorevic is expected to remain at the helm of the soon-to-be joint company, while Livongo’s CEO and founder Glen Tullman will be taking up a seat on the Teladoc board.
Teladoc plans to buy Livongo...
